HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Net Shares Issued and Repurchased (2015 - 2024)

HUTCHMED (China)'s (HMDCF) quarterly Net Shares Issued and Repurchased came in at -$36.1 million in Q4 2024, down 297.57% year-over-year from $18.3 million in Q1 2024, and little changed quarter-over-quarter from -$36.1 million in Q2 2024.

Analysis

HUTCHMED (China) (HMDCF) Net Shares Issued and Repurchased (2015 - 2024) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Net Shares Issued and Repurchased for 10 consecutive years, with -$36.1 million the latest figure, recorded in Q4 2024.

  • On a quarterly basis, Net Shares Issued and Repurchased fell 297.57% year-over-year to -$36.1 million in Q4 2024; TTM through Dec 2024 was -$36.1 million, a 297.57% decrease from a year earlier, with the FY2024 full-year figure at -$36.1 million, down 297.57% from the prior year.
  • Net Shares Issued and Repurchased was -$36.1 million for Q4 2024 at HUTCHMED (China), roughly flat from -$36.1 million in the prior quarter.
  • Over five years, Net Shares Issued and Repurchased peaked at -$9.1 million in Q2 2023 and troughed at -$48.1 million in Q2 2022.
  • A 5-year average of -$26.6 million and a median of -$26.8 million in 2021 frame the typical range for Net Shares Issued and Repurchased.
  • Across the five-year window, Net Shares Issued and Repurchased tumbled 3629.48% in 2020 and soared 81.14% in 2023, its largest moves.
  • Over 5 years, Net Shares Issued and Repurchased stood at -$12.9 million in 2020, then sank by 111.63% to -$27.3 million in 2021, then slumped by 76.07% to -$48.1 million in 2022, then soared by 81.14% to -$9.1 million in 2023, then slumped by 297.57% to -$36.1 million in 2024.
  • The last three Net Shares Issued and Repurchased figures came in at -$36.1 million (Q4 2024), -$36.1 million (Q2 2024), and -$9.1 million (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 211.50 Bn 197.51 Bn 7.24 Bn -
2 Gilead Sciences 181.29 Bn 178.11 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.55 Bn 74.56 Bn 3.93 Bn -
5 Argenx Se 61.65 Bn 56.47 Bn 1.37 Bn -
6 Moderna 54.65 Bn 49.52 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.18 Bn 30.87 Bn 992.69 Mn -
8 Biogen 31.36 Bn 30.07 Bn 1.96 Bn -
9 Roivant Sciences 30.01 Bn 30.01 Bn 1.16 Mn -
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -36.06 Mn
Jun 30, 2024 -36.06 Mn
Dec 31, 2023 -9.07 Mn
Jun 30, 2023 -9.07 Mn
Dec 31, 2022 -48.08 Mn
Jun 30, 2022 -48.08 Mn
Dec 31, 2021 -27.31 Mn
Jun 30, 2021 -26.76 Mn
Mar 31, 2021 -26.76 Mn
Dec 31, 2020 -12.90 Mn
Jun 30, 2020 -12.90 Mn
Dec 31, 2019 -346,000.00
Sep 30, 2019 -346,000.00
Jun 30, 2019 -346,000.00
Mar 31, 2019 -346,000.00
Dec 31, 2018 5.45 Mn
Sep 30, 2018 -5.45 Mn
Jun 30, 2018 -5.45 Mn
Mar 31, 2018 -5.45 Mn
Dec 31, 2017 1.37 Mn